Trending Reports

Quick Access to
Research Assistance

We can help you find what you need. Get in touch with us.

Get Alerts!

Receive e-mail alerts on latest market research

Drug Delivery - Global Market Research

Drug Delivery - Global Market Research

Refine Search
Show
per page

Liver Cancer Drug Pipeline Update 2013

There are today 164 companies plus partners developing 196 drugs targeting liver cancer in development. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 52 drugs. Liver Cancer D....

Drug Delivery | Aug 20th, 2013 | by BioSeeker

Industry : Healthcare

Read more

$1,498

Pancreatic Cancer Drug Pipeline Update 2013

There are today 258 companies plus partners developing 299 drugs targeting pancreatic cancer in development. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 107 drugs. Pancreat....

Drug Delivery | Aug 20th, 2013 | by BioSeeker

Industry : Healthcare

Read more

$2,248

Peptides in Oncology Drug Pipeline Update 2013

There are today 233 companies plus partners developing 218 peptide drugs in 516 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 124 drugs. Pep....

Drug Delivery | Aug 20th, 2013 | by BioSeeker

Industry : Healthcare

Read more

$2,248

PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2013

The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival. The....

Drug Delivery | Aug 20th, 2013 | by BioSeeker

Industry : Healthcare

Read more

$2,998

Prostate Cancer Drug Pipeline Update 2013

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players sales have been eroded by the launch of various LHRH agonist depot formulations. Safety concern....

Drug Delivery | Aug 20th, 2013 | by BioSeeker

Industry : Healthcare

Read more

$2,248
Show
per page